OMV CoS 46 09/2025/ AT0000A3C2T5 /
1/23/2025 5:28:09 PM | Chg.+0.82 | Bid5:28:09 PM | Ask5:28:09 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
100.84EUR | +0.82% | 100.84 Bid Size: - |
101.09 Ask Size: - |
OMV AG | 46.00 EUR | 9/24/2025 | Call |
GlobeNewswire
3/26/2024
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16/2024
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center